Oculis Holding AG (OCS) Long-Term Investments (2021 - 2025)

Oculis Holding AG's (OCS) quarterly Long-Term Investments came in at $239.1 million in Q4 2025, up 9.61% year-on-year from $218.1 million in Q4 2024, and up 9.61% quarter-over-quarter from $218.1 million in Q4 2024.

Oculis Holding AG (OCS) Long-Term Investments (2021 - 2025) Analysis & Trends

Oculis Holding AG's Long-Term Investments history runs 5 years deep, the most recent figure standing at $239.1 million for Q4 2025.

  • On a quarterly basis, Long-Term Investments rose 9.61% year-over-year to $239.1 million in Q4 2025; TTM through Dec 2025 was $239.1 million, a 9.61% increase from a year earlier, with the FY2025 full-year figure at $230.5 million, up 6.11% from the prior year.
  • Long-Term Investments grew to $239.1 million in Q4 2025 per OCS's latest filing, from $218.1 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $239.1 million in Q4 2025 and bottomed at $51901.1 in Q4 2022.
  • The 5-year median for Long-Term Investments is $215.4 million (2023), against an average of $134.5 million.
  • Across the five-year window, Long-Term Investments decreased 7.97% in 2022 and soared 414920.6% in 2023, its largest moves.
  • Year by year, Long-Term Investments stood at $56394.1 in 2021, then slipped by 7.97% to $51901.1 in 2022, then surged by 414920.6% to $215.4 million in 2023, then gained by 1.26% to $218.1 million in 2024, then rose by 9.61% to $239.1 million in 2025.
  • Per Business Quant, the three latest OCS Long-Term Investments figures stand at $239.1 million (Q4 2025), $218.1 million (Q4 2024), and $215.4 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 505,194.89
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 5.75 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 9.79 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 22.17 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 239.06 Mn
Dec 31, 2024 218.11 Mn
Dec 31, 2023 215.40 Mn
Dec 31, 2022 51,901.10
Dec 31, 2021 56,394.11